Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6780
+0.0174 (2.63%)
At close: Oct 2, 2026, 4:00 PM EDT
0.6612
-0.0168 (-2.48%)
After-hours: Oct 2, 2026, 4:10 PM EDT

Envoy Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22
0.050.040.080.040.080.050.040.060.070.060.10.080.060.080.020.060.060.1
Revenue Growth (YoY)
-34.62%-15.22%78.57%-25.00%14.71%-22.03%-55.79%-30.00%7.94%-24.36%375.00%40.35%6.78%-22.77%----
Cost of Revenue
0.280.310.020.20.230.230.160.190.250.150.230.190.160.180.150.110.220.21
Gross Profit
-0.23-0.270.05-0.16-0.16-0.18-0.12-0.13-0.18-0.09-0.14-0.11-0.1-0.1-0.13-0.05-0.16-0.11
Selling, General & Admin
2.212.041.72.852.432.181.962.082.082.433.531.432.231.751.330.810.670.65
Research & Development
3.133.644.552.72.492.752.472.762.592.363.061.852.151.931.440.941.361.05
Operating Expenses
5.345.696.255.554.914.934.434.844.684.796.583.284.383.672.781.752.041.7
Operating Income
-5.57-5.96-6.2-5.71-5.07-5.11-4.55-4.97-4.85-4.88-6.72-3.39-4.48-3.77-2.91-1.8-2.19-1.81
Interest Expense
----0.47-0.62-0.5-0.38-0.26-0.13-0.04--------
Other Non Operating Income (Expenses)
-0.411.61-0.2-0.300.60.32-0.721.04-1.351.830.05-8.77-0.11-1.480.460.96-0.06
EBT Excluding Unusual Items
-5.98-4.35-6.4-6.48-5.69-5-4.62-5.96-3.95-6.27-4.9-3.34-13.25-3.88-4.39-1.34-1.24-1.87
Other Unusual Items
---0.19--------4.9--9.38-7.09---
Pretax Income
-5.98-4.35-6.59-6.48-5.69-5-4.62-5.96-3.95-6.27-4.91.56-13.25-13.25-11.48-1.34-1.24-1.87
Net Income
-5.98-4.35-6.59-6.48-5.69-5-4.62-5.96-3.95-6.27-4.91.56-13.25-13.25-11.48-1.34-1.24-1.87
Preferred Dividends & Other Adjustments
1.291.351.151.271.251.243.071.381.371.371.350.2----0.50.5
Net Income to Common
-7.27-5.7-7.74-7.75-6.94-6.24-7.69-7.34-5.31-7.64-6.241.36-13.25-13.25-11.48-1.34-1.74-2.37
Net Income Growth (YoY)
------------------
Shares Outstanding (Basic)
104692822212119191919191010101010139139
Shares Outstanding (Diluted)
104692822212119191919191110101010139139
Shares Change (YoY)
386.53%223.23%47.17%17.38%14.97%14.66%3.34%65.99%83.75%83.75%84.93%10.79%-92.73%-92.73%----
EPS (Basic)
-0.07-0.08-0.27-0.35-0.32-0.29-0.40-0.39-0.29-0.41-0.330.13-1.31-1.31-1.13-0.13-0.01-0.02
EPS (Diluted)
-0.07-0.08-0.27-0.35-0.32-0.29-0.40-0.39-0.29-0.41-0.340.13-1.31-1.31-1.13-0.13-0.01-0.02
EPS Growth (YoY)
------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22
Free Cash Flow
-5.46-6.06-5.86-4.33-4.46-3.73-4.56-3.24-5.44-5.7-11.171.04-4.05-3.07-2.42-2.55-2.05-2
Free Cash Flow Per Share
-0.05-0.09-0.21-0.20-0.21-0.17-0.24-0.17-0.29-0.31-0.600.09-0.40-0.30-0.24-0.25-0.01-0.01
Gross Margin
--72.00%--200.00%--273.81%-233.93%-260.29%-159.32%-146.32%-136.25%-157.14%-124.36%--85.97%-269.49%-110.89%
Operating Margin
-10919.61%-15279.49%-8260.00%-13590.48%-6500.00%-11102.17%-10830.95%-8878.57%-7135.29%-8277.97%-7076.84%-4231.25%-7111.11%-4834.61%-14530.00%-3150.88%-3718.64%-1792.08%
Profit Margin
-14258.82%-14617.95%-10316.00%-18445.24%-8900.00%-13556.52%-18300.00%-13107.14%-7811.76%-12940.68%-6572.63%1700.00%-21025.40%-16991.03%-57385.00%-2349.12%-2942.37%-2347.53%
Free Cash Flow Margin
-10709.80%-15541.03%-7809.33%-10311.91%-5719.23%-8110.87%-10850.00%-5782.14%-7994.12%-9657.63%-11753.68%1296.25%-6420.64%-3935.90%-12100.00%-4480.70%-3466.10%-1984.16%
EBITDA
-5.5-5.89-6.12-5.63-4.99-5.05-4.5-4.92-4.81-4.85-6.68-3.36-4.45-3.74-2.88-1.77-2.18-1.8
D&A For EBITDA
0.070.070.080.080.090.060.050.050.040.030.050.030.030.030.030.020.010.01
EBIT
-5.57-5.96-6.2-5.71-5.07-5.11-4.55-4.97-4.85-4.88-6.72-3.39-4.48-3.77-2.91-1.8-2.19-1.81
SEC Filings: 10-K · 10-Q